Carolinas Inc - Local Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Drug Manufacturers - Major Sector (CIX: MSECTOR510)
1,578.78   +2.22 (+0.14%)
Streaming Delayed Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Sector News
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Open 1571.34
Prev. Close 1576.56
Today's Range 1562.43 - 1582.17
52wk Range 1200.95 - 1615.95
Components
View All
Value % Change
Johnson & Johnson  86.82
-0.45%
Pfizer, Inc.  29.04
-0.24%
Novartis AG ADS  74.36
+0.73%
Sanofi-Aventis ADS  54.86
+0.55%
GlaxoSmithKline PLC ADS  52.97
+0.46%
Bristol-Myers Squibb Co.  47.40
+0.85%
AstraZeneca PLC ADS  52.17
+0.17%
Eli Lilly & Co.  54.14
-1.10%
Abbott Laboratories  37.76
+0.75%
Wuxi Pharmatech  20.48
-1.96%
Top News
More News
Obamacare Will Bring Drug Industry $35 Billion In Profits
Today 10:29 EDT
Despite expiring patents on blockbuster drugs and a wave of new regulation from the Affordable Care Act that will cost drug makers, the pharmaceutical industry will reap between “$10 billion and $35... Read More
from Forbes Real Time
Start Making Profits Now With ANF, VRX, JNJ and GLW
Today 10:00 EDT
from Marketwired News Releases
Big Pharma Learned The Wrong Marketing Lesson
Today 8:30 EDT
Large pharmaceutical companies like Pfizer and Merck are often celebrated for their marketing acumen. But, when compared with really successful marketing companies like the Internet giant Google, their... Read More
from Forbes Real Time
More News
More News
Week in Review: Hisun-Pfizer and Merck-Simcere JVs Come Into Focus
Today 3:42 EDT
Zhejiang Hisun Pharma contributed 75 drug products to gain 51% control of its JV with Pfizer, while Pfizer added eight drugs; the Merck-Simcere JV is focused onsix cardiovascular drugs, two from... Read More
from ChinaBio® Today
In the Know, Smart Investing in PHM, CX, JNJ and PPL
May 24, 2013
from Marketwired News Releases
Rivaroxaban Gains Approval In Europe For ACS Indication
May 24, 2013
Rivaroxaban (Xarelto, Bayer) has been approved in Europe for the prevention of atherothrombotic events (cardiovascular death, myocardial infarction or stroke) following an acute coronary syndrome... Read More
from Forbes Real Time
Bristol-Myers Squibb Co. (BMY) Shares Cross 3% Yield Mark
May 24, 2013
In trading on Friday, shares of Bristol-Myers Squibb Co. (BMY) were yielding above the 3% mark based on its quarterly dividend (annualized to $1.40), with the stock changing hands as low as $45.81 on... Read More
from Dividend Channel
Movers and Shakers: A look at who in bio is coming and going
May 24, 2013
The following personnel announcements at New England-area biotech companies have been made in recent weeks: Cambridge, Mass... Read More
from Business Journals

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here